Manufacturer
20 recalls in our database name AbbVie Inc. as the manufacturing or recalling firm.
Of the 20 recalls from AbbVie Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2 (10%) are Severe.
Which agencies issued them
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Pred Mild prednisolone acetate ophthalmic suspension 0.12% is being recalled after failing stability specifications. 2,736 bottles are affected.
Allergen is recalling specific lots of Refresh LACRI-LUBE eye ointment (763,426 tubes) due to potential breaches in the tube seal that may compromise sterility. Consumers should verify their product lot number against the recall list.
AbbVie is recalling Refresh P.M. lubricant eye ointment due to potential breaches in tube seals that may compromise product sterility. Approximately 2.4 million tubes were distributed nationwide and internationally.
AbbVie is recalling 864 cartons of Synthroid (Levothyroxine Sodium) 125mcg tablets due to incorrect barcode labeling. About 1 in 40 blister packs has a barcode showing 200mcg instead of 125mcg, risking dosage confusion.
AbbVie Inc. is recalling 7,770 bottles of Ultane (sevoflurane) inhalation anesthetic due to defective container caps that may leak.
AbbVie is recalling specific lots of AndroGel testosterone gel because prolonged exposure to temperatures outside labeled storage conditions may have affected the product.
AbbVie is recalling 48 cartons of AndroGel testosterone gel distributed in Arizona due to prolonged exposure to temperatures outside labeled storage conditions.
AbbVie Inc. is voluntarily recalling 673 PEG kits because they may not be sterile. The recall covers lots distributed nationwide and internationally.
AbbVie is recalling specific lots of PEG Kits due to potential defects including missing components, duplicate parts, or missing labels and instructions.
AbbVie is recalling 3,331 PEG kits distributed in the US and 31 other countries because they may have missing components, duplicate parts, or missing labels.
AbbVie is recalling Duopa (carbidopa and levodopa) cassettes because stability testing showed the drug may settle near the end of its shelf life.
AbbVie is issuing an urgent field correction for 20 FR PEG Kits due to increased reports of tube disconnections from Y-connectors.
AbbVie is recalling 307 bottles of Zemplar (paricalcitol) capsules nationwide because the product failed content uniformity specifications.
AbbVie is recalling 18,021 bottles of CREON (pancrelipase) capsules because some bottles contain foreign tablets or co-mingled LipaCreon 13000.
AbbVie is recalling 36 kits of Lupron Depot 45 mg due to a potentially defective needle stick protection device.
AbbVie is recalling 7,362 Lupron Depot kits because some may contain a syringe with a defective needle stick protection device.
AbbVie is recalling 12 kits of Lupron Depot-Ped due to a potentially defective needle stick protection device.
AbbVie is recalling 2,915 Lupron Depot kits because the syringe needle protection device may be defective. The recall covers nationwide distribution and Puerto Rico.
AbbVie is recalling 1,530 Lupron Depot kits because some may contain a syringe with a defective needle stick protection device.
AbbVie is recalling 704 bottles of Mavik trandolapril tablets 4mg because they were packaged with an outdated version of the package insert.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
AbbVie
pharmaceutical company
Source: Wikidata (Q14662364), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.